Pieris
Acquired- Headquarters
- Hallbergmoos
- Employees
- 51–200
- Business Model
- B2B
- Website
- pieris.com
About
Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering Anticalin proteins - a novel class of therapeutic biologics derived from human lipocalins. The company focuses on bispecific fusion proteins targeting oncology and respiratory diseases.
Summary
Pieris is a Biotech company based in Hallbergmoos, Germany. Investors include Bayern Kapital and Forbion Capital Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...